Effect of nitric oxide in protective effect of melatonin against chronic constriction sciatic nerve injury induced neuropathic pain in rats

Indian Journal of Experimental Biology

Volumn 49, Issue 9, 2011, Pages 664-671

  Kumar, Anil ^a   Meena, Seema ^a   Kalonia, Harikesh ^a   Gupta, Amit ^a   Kumar, Puneet ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Allodynia; Chronic constriction injury; Hyperalgesia; Melatonin; Neuropathic pain

Indexed keywords

ANTIOXIDANT; ARGININE; CATALASE; GLUTATHIONE; MELATONIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL; ARTICLE; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECT; HYPERALGESIA; INJURY; LIPID PEROXIDATION; MALE; METABOLISM; NEURALGIA; OXIDATIVE STRESS; PHYSIOLOGY; RAT; SCIATIC NERVE; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ARGININE; CATALASE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GLUTATHIONE; HYPERALGESIA; LIPID PEROXIDATION; MALE; MELATONIN; NEURALGIA; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SCIATIC NERVE;

ANIMALIA; RATTUS;

EID: 80052467106     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Attal N & Bshassria D, Can pain be more or less neuropathic? Pain, 110 (2004) 5101.
2. Moalem G & Tracey DJ, Immune and inflammatory mechanisms in neuropathic pain, Brain Res Rev, 51 (2006) 240.
3. Leung L & Cahill CM, TNF-alpha and neuropathic pain-A review, J Neuroinflammation, 7 (2010) 27.
4. Gila M & David T, Immune and inflammatory mechanism in neuropathic pain, Brain Res Rev, 51 (2006) 240.
5. Kim HK, Park SK, Zhou JL, Taglialatela G, Chung K, Coggeshall RE & Chung JM, Reactive oxygen species (ROS) play an important role in rat model of neuropathic pain, Pain, 111 (2004) 1116.
6. Vanelderen P, Rouwette T, Kozicz T, Roubos E, Zundert JV, Heylen R & Vissers K, The role of brain-derived neurotrophic factor in different animal models of neuropathic pain, Eur J Pain, (2009); doi:10.1016/j.ejpain.2009.09.006
7. Benbouzid M, Pallage V, Rajalu M, Waltisperger E, Doridot S, Poisbeau P, Freund-Mercier MJ & Barrot M, Sciatic nerve cuffing in mice: A model of sustained neuropathic pain, Eur J Pain, 12 (2008) 591.
8. Zhang XJ, Zhang TW, Hu SJ & Xu H, Behavioral assessments of the aversive quality of pain in animals, Neurosci Bull, 27 (2011) 61.
9. Ambriz-Tututi M, Rocha-González HI, Cruz SL & Granados-Soto V, Melatonin: A hormone that modulates pain, Life Sci, 84 (2009) 489.
10. Dowdall T, Robinson I & Meert TF, Comparison of five different rat models of peripheral nerve injury, Pharmacol Biochem Behav, 80 (2005) 93.
11. Lindenlaub T & Sommer C, Partial sciatic nerve transaction as a model of neuropathic pain: A qualitative and quantitative neuropathological study, Pain, 89 (2000) 97.
12. Chen H, Lamer TJ & Rho RH, Contemporary management of neuropathic pain for the primary care physician, Mayo Clin Proc, 79 (2004) 1533.
13. Choi Y, Raja SN, Moore LC & Tobin JR, A neuropathic pain rat is associated with altered nitric oxide synthase activity in neural tissue, J Neurol Sci, 138 (1996) 14.
14. Gordh T, The role of nitric oxide in neuropathic pain and neurodegeneration, Acta Anaesthesiol Scand, 42 (1998) 29.
15. Hao JX & Xu XJ, Treatment of a chronic allodynia-like response in spinally injured rats: Effects of systemically administered nitric oxide synthase inhibitors, Pain 66 (1996) 313.
16. Kitto KF, Haley JE & Wilcox GL, Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse, Neurosci Lett, 148 (1992) 1.
17. Nam E, Lee SM, Koh SE, Joo WS, Maeng S, Im HI & Kim YS, Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum, Brain Res, 1046 (2005) 90.
18. Zheng W, Ouyang H, Zheng X, Liu S, Mata M, Fink DJ & Hao S, Glial TNFalpha regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain, 7 (2011) 40.
19. Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD & Saarela S. Melatonin as a free radical scavenger: implications for aging and age-related diseases, Ann N Y Acad Sci, 719 (1994) 1.
20. Reiter RJ, Tang L, Garcia JJ & Munoz-Hoyos A, Pharmacological actions of melatonin in oxygen radical pathophysiology, Life Sci, 60 (1997) 2255.
21. Rogerio F, De S, Queiroz L, Teixeira SA, Oliveira AL, de Nucci G & Langone F, Neuroprotective action of melatonin on neonatal rat motoneurons after sciatic nerve transaction, Brain Res, 926 (2000) 33.
22. Yu CX, Wu C, Xu SF & Chen CH, Effect of melatonin on release of endogenous opioid peptides in rat periaqueductal gray, Act Physiol Sin, 21 (2000) 421.
23. Sayan H, Ozacmak VH, Ozen OA, Coskun O, Arslan SO, Sezen SC & Aktas RG, Beneficial effects of melatonin on reperfusion injury in rat sciatic nerve, J Pineal Res, 37 (2004) 143.
24. Sayan H, Ugurla B, Babul A, Take G & Erdogan D, Effects of L-arginine and NG-Nitro-L-arginine methyl ester on lipid peroxide, superoxide dismutase and nitrate levels after experimental sciatic nerve ischemia-reperfusion in rats, Int J Neurosc, 114 (2004) 349.
25. Raghavendra V, Agrewala JN & Kulkarni SK, Melatonin reversal of lipopolysaccharide-induced thermal and behavioral hyperalgesia in mice, Eur J Pharmacol, 395 (2000) 15.
26. Raghavendra V & Kulkarni SK, Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice, Eur J Pharmacol, 409 (2000) 279.
27. Yu CH, Zhu CB, Xu SF, Cao XD & Wu GC, Selective MT2 melatonin receptor antagonist blocks melatonin-induced antinociception in rats, Neuro Lett, 282 (2000) 161.
28. Yu H, Zhu CB, Xu SF, Cao XD & Wu GC, The analgesic effects of peripheral and central administration of melatonin in rats, Eur J Pharmacol, 403 (2000) 49.
29. Kumar A, Garg R, Gaur V & Kumar P, Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice, Brain Res, 1311 (2010) 73.
30. Kumar A, Garg R & Kumar P, Nitric oxide modulation mediates the protective effect of trazodone in a mouse model of chronic fatigue syndrome, Pharmacol Rep, 60 (2008) 664.
31. Aashish SM & Subhash LB, Neuroprotective effect of vitamin E acetate in models of mononeuropathy in rats, Neuroanatomy, 7 (2008) 33.
32. Hahm ET, Kim Y, Lee JJ & Cho YW, GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain. BMC Neurosci, 12 (2011) 41.
33. Wills ED, Mechanism of lipid peroxide formation in animal tissues, Biochem J, 99 (1966) 667.
34. Ellman GL, Tissue sulfhydryl groups, Arch Biochem Biophys, 82 (1959) 70.
35. Green LC, Wagner A & Glagowski J, Analysis of nitrate, nitrite and [15N] nitrate in biological fluids, Anal Biochem, 126 (1982) 131.
36. Luck H, Methods of enzymatic analysis, edited by HU Bergmeyer, (Academic Press, New York) 1971, 885.
37. Gornall AG, Bardawill CJ & David MM, Determination of serum proteins by means of the biuret reaction, J Biol Chem, 177 (1949) 751.
38. Michael I, Bennett GJ, Blair HS, Torrance N & Lee A, Can pain be more or less neuropathic? Comparison of symptom assessment tools with rating of certainty by clinicians, Pain, 122 (2006) 289.
39. Nilsson E, Nakamae T & Olmarker K, Pain behavior changes following disc puncture relate to nucleus pulposus rather than to the disc injury per se: An experimental study in rats, Open Orthop J, 5 (2011), 72.
40. Malmberg AB & Basbaum AI, Partial sciatic nerve injury in the mouse as a model of neuropathic pain: Behavioral and neuroanatomical correlates, Pain, 76 (1998) 215.
41. Pitcher GM, Ritchie J & Henry JL, Nerve constriction in the rat: Model of neuropathic, surgical and central pain, Pain, 83 (1999) 37.
42. Crisp T, Giles JR, Cruce WL, McBurney DL & Stuesse SL, The effects of aging on thermal hyperalgesia and tactileevoked allodynia using two models of peripheral mononeuropathy in the rat, Neurosci Lett, 339 (2003) 103.
43. Dableh LJ & Henry JL, The selective neuronal nitric oxide synthase inhibitor 7-nitroindazole has acute analgesic but not cumulative effects in a rat model of peripheral neuropathy. J Pain Res, 4, (2011), 85.
44. Ossipov MH, Bian D, Malan Jr TP, Lai J & Porreca F, Lack of involvement of capsacin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats, Pain, 79 (1999) 127.
45. Poisbeau P, Patte-Mensah C, Keller AF, Barrot M, Breton JD, Luis-Delgado OE, Freund-Mercier MJ, Mensah-Nyagan AG & Schlichter R, Inflammatory pain upregulates spinal inhibition via endogenous neurosteroid production, J Neurosci, 25 (2005) 11768.
46. Osikowicz M, Makuch W, Przewlocka B & Mika J, Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic, Pain, 139 (2008) 117.
47. Wang T, Li SR, Dai X, Peng YL, Chen Q & Wang R, Effects of melatonin on orphanin FQ/nociceptin-induced hyperalgesia in mice, Brain Res, 26 (2006) 1085.
48. Naik AK, Tandan SK, Dudhgaonkar SP, Jadhav SH, Kataria M, Prakash VR & Kumar D, Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats, Eur J Pain, 10 (2006) 573.
49. Muthuraman A, Jaggi AS, Singh N & Singh D, Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats, Eur J Pharmacol, 10 (2008) 104.
50. Dableh LJ & Henry JL, Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical, J Pain Res, 4 (2011), 91.
51. Khalil Z & Khodr B, A role for free radicals and nitric oxide in delayed recovery in aged rats with chronic constriction nerve injury, Free Free Radic Biol Med, 31 (2001) 430.
52. Ulugol A, Dokmeci D, Guray G, Sapolyo N, Ozyigit F & Tamer M, Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the L-arginine-NO pathway and opioid system, Life Sci, 78 (2006) 1592.
53. Hardeland R, Reiter J, Poeggeler B & Tan DX, The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances, Neurosci Biobehav Rev, 17 (1993) 347.
54. Tu Y, Sun RQ & Willis WD, Effects of intrathecal injections of melatonin analogs on capsaicin-induced secondary mechanical allodynia and hyperalgesia in rats, Pain, 109 (2004) 340.
55. Menenga K, Ueck M & Reiter RJ, Immunohistological localization of melatonin in the pineal gland and retina of the rat, J Pineal Res, 10 (1991) 159.
56. Menendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden L, Pablos MI & Tan DX, Nuclear localization of melatonin in different mammalian tissues: Immunocytochemical and radioimmunoassay evidence, J Cell Biochem, 53 (1993) 373.
57. Muthuraman A & Singh N, Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: An evidence of anti-oxidative, antiinflammatory, neuroprotective and calcium inhibitory effects, BMC Complement Altern Med, 11 (2011) 24.
58. Mantovani M, Pertile R, Calixto JB, Santos ARS & Rodrigues ALS, Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-Daspartate receptors and the Larginine-nitric oxide pathway, Neuro Lett, 34 (2003) 1.
59. Schmid U, Stopper H, Heidland A & Schupp N, Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro, Diabetes Metab Res Rev, 24 (2008) 371.
60. Sabedge RC, Hart SL & Moore PK, Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: Dissociation between the effect of L-NAME and L-NMMA, J Pharm Pharmacol, 45 (1993) 77.
61. Meller ST, Pechman PS, Gebhart GF & Maves TJ, Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat, Neuroscience, 50 (1992) 7.